Literature DB >> 11932198

Control of Mycobacterium bovis infections and the risk to human populations.

D Neil Wedlock1, Margot A Skinner, Geoffrey W de Lisle, Bryce M Buddle.   

Abstract

Conventional control methods based on test-and-slaughter policies have, in several countries, led to the successful eradication of bovine tuberculosis in cattle. However, new approaches for control of bovine tuberculosis are required in developing countries and those with a wildlife reservoir of infection. Recent developments include improved diagnostics and evaluation of new vaccination strategies.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11932198     DOI： 10.1016/s1286-4579(02)01562-9

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  16 in total

1.  DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice.

Authors:  Francisco M Teixeira; Henrique C Teixeira; Ana Paula Ferreira; Michele F Rodrigues; Vasco Azevedo; Gilson C Macedo; Sergio C Oliveira
Journal:  Clin Vaccine Immunol       Date:  2006-08

2.  Genotypic characterization by spoligotyping and VNTR typing of Mycobacterium bovis and Mycobacterium caprae isolates from cattle of Tunisia.

Authors:  Hela Lamine-Khemiri; Remigio Martínez; Waldo Luis García-Jiménez; Jose Manuel Benítez-Medina; Maria Cortés; Inés Hurtado; Mohammed Salah Abassi; Imed Khazri; Mohammed Benzarti; Javier Hermoso-de-Mendoza
Journal:  Trop Anim Health Prod       Date:  2013-10-25       Impact factor: 1.559

3.  A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.

Authors:  M A Skinner; A J Ramsay; G S Buchan; D L Keen; C Ranasinghe; L Slobbe; D M Collins; G W de Lisle; B M Buddle
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

4.  Occurrence of overlooked zoonotic tuberculosis: detection of Mycobacterium bovis in human cerebrospinal fluid.

Authors:  N P Shah; A Singhal; A Jain; P Kumar; S S Uppal; M V P Srivatsava; H K Prasad
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

Authors:  Margot A Skinner; Bryce M Buddle; D Neil Wedlock; Denise Keen; Geoffrey W de Lisle; Ricardo E Tascon; Jose Candido Ferraz; Douglas B Lowrie; Paul J Cockle; H Martin Vordermeier; R Glyn Hewinson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

6.  Mycobacteria causing human cervical lymphadenitis in pastoral communities in the Karamoja region of Uganda.

Authors:  J Oloya; J Opuda-Asibo; R Kazwala; A B Demelash; E Skjerve; A Lund; T B Johansen; B Djonne
Journal:  Epidemiol Infect       Date:  2007-06-29       Impact factor: 2.451

7.  Usefulness of the GenoType MTBC assay for differentiating species of the Mycobacterium tuberculosis complex in cultures obtained from clinical specimens.

Authors:  Elvira Richter; Michael Weizenegger; Anne-Marie Fahr; Sabine Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

8.  Prokaryotic expression and functional analysis of the Mb1514 gene in Mycobacterium bovis.

Authors:  Xiaomin Yin; Xiangmei Zhou; Zhixin Xue; Lihong Tian; Yang Zhou; Lifeng Yang; Deming Zhao
Journal:  Mol Cell Biochem       Date:  2013-10-20       Impact factor: 3.396

9.  Risk factors of bovine tuberculosis in cattle in rural livestock production systems of Ethiopia.

Authors:  Rea Tschopp; Esther Schelling; Jan Hattendorf; Abraham Aseffa; Jakob Zinsstag
Journal:  Prev Vet Med       Date:  2009-03-31       Impact factor: 2.670

10.  Variable number tandem repeat analysis of Mycobacterium bovis isolates from Gyeonggi-do, Korea.

Authors:  Bo- Young Jeon; Sungmo Je; Jinhee Park; Yeun Kim; Eun-Gae Lee; Hyeyoung Lee; Sangkyo Seo; Sang-Nae Cho
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.